These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 35203885

  • 1. PK-PD Modeling and Optimal Dosing Regimen of Acetylkitasamycin against Streptococcus suis in Piglets.
    Huang A, Mao F, Huang L, Xie S, Pan Y, Qu W, Cheng G, Liu Z, Yuan Z, Peng D, Hao H.
    Antibiotics (Basel); 2022 Feb 21; 11(2):. PubMed ID: 35203885
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic and pharmacodynamic integration and modeling of acetylkitasamycin in swine for Clostridium perfringens.
    Nan J, Hao H, Xie S, Pan Y, Xi C, Mao F, Liu Z, Huang L, Yuan Z.
    J Vet Pharmacol Ther; 2017 Dec 21; 40(6):641-655. PubMed ID: 28464333
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic-pharmacodynamic modeling of tylosin against Streptococcus suis in pigs.
    Huang L, Zhang H, Li M, Ahmad I, Wang Y, Yuan Z.
    BMC Vet Res; 2018 Oct 24; 14(1):319. PubMed ID: 30355326
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. PK-PD Integration Modeling and Cutoff Value of Florfenicol against Streptococcus suis in Pigs.
    Lei Z, Liu Q, Yang S, Yang B, Khaliq H, Li K, Ahmed S, Sajid A, Zhang B, Chen P, Qiu Y, Cao J, He Q.
    Front Pharmacol; 2018 Oct 24; 9():2. PubMed ID: 29387013
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determination of Susceptibility Breakpoint for Cefquinome against Streptococcus suis in Pigs.
    Mi K, Li M, Sun L, Hou Y, Zhou K, Hao H, Pan Y, Liu Z, Xie C, Huang L.
    Antibiotics (Basel); 2021 Aug 09; 10(8):. PubMed ID: 34439008
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Exploration of Clinical Breakpoint of Danofloxacin for Glaesserella parasuis in Plasma and in PELF.
    Xu Z, Huang A, Luo X, Zhang P, Huang L, Wang X, Mi K, Fang S, Huang X, Li J, Yuan Z, Hao H.
    Antibiotics (Basel); 2021 Jul 02; 10(7):. PubMed ID: 34356730
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimal Regimens and Cutoff Evaluation of Tildipirosin Against Pasteurella multocida.
    Lei Z, Liu Q, Qi Y, Yang B, Khaliq H, Xiong J, Moku GK, Ahmed S, Li K, Zhang H, Zhang W, Cao J, He Q.
    Front Pharmacol; 2018 Jul 02; 9():765. PubMed ID: 30093860
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antibacterial activity of cyadox against Clostridium perfringens in broilers and a dosage regimen design based on pharmacokinetic-pharmacodynamic modeling.
    Wang F, Mi K, Ahmad I, Xie S, Hussain HI, Yuan Z, Dai M, Huang L.
    Microb Pathog; 2020 Apr 02; 141():103981. PubMed ID: 31962185
    [Abstract] [Full Text] [Related]

  • 18. Optimal Regimens and Clinical Breakpoint of Avilamycin Against Clostridium perfringens in Swine Based on PK-PD Study.
    Huang A, Luo X, Xu Z, Huang L, Wang X, Xie S, Pan Y, Fang S, Liu Z, Yuan Z, Hao H.
    Front Pharmacol; 2022 Apr 02; 13():769539. PubMed ID: 35281904
    [Abstract] [Full Text] [Related]

  • 19. Population pharmacokinetic and pharmacodynamic modeling of high-dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients.
    Zobell JT, Stockmann C, Young DC, Cash J, McDowell BJ, Korgenski K, Sherwin CM, Spigarelli M, Chatfield BA, Ampofo K.
    Clin Ther; 2011 Nov 02; 33(11):1844-50. PubMed ID: 22018680
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.